Seeking Alpha
View as an RSS Feed

Robert Fabian  

View Robert Fabian's Comments BY TICKER:
Latest  |  Highest rated
  • OvaScience: Understanding The Data And Why Buy Now? [View article]
    " Robert, it surprises me that a donor mitochondria is acceptable to you while a mother's own mitochondria is not? Did UK just not pass the legislation for donor mitochondria?"

    What are you talking about? The UK legislation was dealing with preventing "inherited mitochondrial diseases". The Augment procedures purpose is nothing to do with that. Ovascience unsubstantiated claim is that by manipulating the egg they can give it an "energy bust" thus increasing the womans chance of giving birth. This is what i don't find acceptable.

    "I am not discrediting FDA for regulating treatments, but sometimes we need to step back and judge whether there is merit in asking for a multi year extensive study when it may not be necessary."

    I'm shocked that people like you think a procedure, that manipulates a womans egg, should not be approved via a large rigorous safety/efficacy clincial trial. Thankfully people like you aren't running the FDA.

    "It's just a matter of few months to prove whether the naysayers were right. The first baby is on its way. "

    So when the first baby is born it is proof that the Augment procedure worked? Did it ever occur to you that the IVF procedure, which the woman also underwent, had given her nearly the SAME chance of giving birth? And this is based off tiny trial data for the Augment treatment which is worthless from a statistical viewpoint. Nah sure it's definitely the new unproven unregulated LAST RESORT treatment that helped those DESPERATE women. What a money maker. :(
    Apr 11, 2015. 06:00 AM | 1 Like Like |Link to Comment
  • OvaScience: Understanding The Data And Why Buy Now? [View article]
    "Particularly its not worthwhile for OVAS to invest their time & effort in IND and subsequent studies as 90% of IVF treatments are done outside US"

    A new procedure that involves the manipulation of a womans eggs should not even go through a large rigorous clinical trial? Why bother when you can sell this "last resort" treatment - to DESPERATE people - unregulated in other countries.

    "I hope that FDA relaxes their concerns given the huge benefit to the women who are struggling to conceive."

    This was a tiny trial sample size. There is NO WAY to say from a statistical viewpoint there was any benefit. Thankfully the FDA are very concerned with this NEW treatment.
    Apr 10, 2015. 02:55 PM | Likes Like |Link to Comment
  • Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq [View article]
    Covered all my shares the last 2 days. One of my best short trades ever. Thank you to Joe Natural, Joe Springer and James Burke for all your pumping. Hopefully you all learned a valuable lesson. RF
    Aug 18, 2014. 04:21 PM | 2 Likes Like |Link to Comment
  • Kandi Technologies: Concerns Over Recent 10-Q Have No Merit [View article]
    "If KNDI is not trying to take advantage of shareholders, then KNDI needs to clarify the EV parts business, stop with fluff PRs, have conference calls, get real analyst coverage, and have a responsive IR department."

    All of this and you were still LONG until you read the last 10-Q recently. ;) I love a good short story but can't stand charlatans like you. You're the reason people hate shorts. Stick to the facts Ben.

    Best,

    Robert
    Jul 24, 2014. 01:37 PM | 4 Likes Like |Link to Comment
  • Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq [View article]
    "Robert, the fact remains .... I can out trade you blindfolded."

    You don't know me from Adam yet it doesn't seem to stop you from making an adsurd statement like this. Clearly there is something wrong with you and this is even more apparent by your constant need to be right when you are clearly wrong. Your ADMP articles lacked the most basic understanding of the workings of a small development stage biotech like ADMP and this is why only people like you were surprised at the shelf filing. You've so much to learn JoesNatural but people like you will never strive to learn more because you are too busy telling others how great you are and how you made 100% in one of the greatest Bull markets of our time. It's laughable. :)
    Jun 25, 2014. 09:19 AM | Likes Like |Link to Comment
  • Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq [View article]
    "$50M shelf gets them ready to sell at their price and the amount they want when and if they need to."

    No, it gets them ready to sell at what ever price they can get as determined by the capital markets.

    Management will dilute this stock into oblivion. IMO.
    Jun 25, 2014. 09:00 AM | Likes Like |Link to Comment
  • Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq [View article]
    " Robert, I just happen to be honest about my trades and position on a stock. I knew the 10-K was coming and that it wouldn't be viewed favorably cash-position wise. While some may want to buy and hold, that's not me, especially after the webcast turned out to be an event where questions could not be asked."

    Honest? LOL. On 18th June (post-webcast) you said "First buy here at $5.10 because ......I didn't see the flush I was expecting when the stock traded briefly below $5.00....but will scale back in (as always) starting down here". Then a few days later you expect readers to believe you "Sold ALL". You're a joke and you're craving for credibility is embarrassing. :)
    Jun 25, 2014. 08:57 AM | Likes Like |Link to Comment
  • Adamis Pharmaceuticals: Still No Love After Uplisting To Nasdaq [View article]
    "Sold ALL of my $5.10's at $5.33"

    Just last week this poster said:

    "First buy here at $5.10 because ......I didn't see the flush I was expecting when the stock traded briefly below $5.00 ..... I sold my last position at $5.42 after the webcast that I was disappointed with, but will scale back in (as always) starting down here, solely on valuation basis and call I had with IR's Mark Flather."

    JoesNaturals posts are laughable. He has zero credibility. :)
    Jun 24, 2014. 08:59 AM | 3 Likes Like |Link to Comment
  • 4 Reasons Adamis Pharmaceuticals Could Be A Multi-Bagger [View article]
    "He may also be a hired gun for a competitor.."

    ROTFLMAO!! Trust me when i tell you this - NO ONE cares what Adamis are doing now or what they plan to do in the future.

    "He may be short the stock but that does not seem to be worth the risk @ these levels..."

    ADMP will be trading in the $3's just before they start the Pivotal Clincial Trial for the Taper DPI. IMO.
    May 27, 2014. 08:34 AM | Likes Like |Link to Comment
  • 4 Reasons Adamis Pharmaceuticals Could Be A Multi-Bagger [View article]
    Management will DILUTE this stock into oblivion. They NEED $10m for the new molds BEFORE they can begin the pivotal trial for the Taper DPI device. This does not include any trial expenses. Chances of upfront payment from a partner are tiny. IMO.

    One of the most HYPED stocks on the chat boards currently. Keep drinking the koolaid.
    May 27, 2014. 08:21 AM | Likes Like |Link to Comment
  • 4 Reasons Adamis Pharmaceuticals Could Be A Multi-Bagger [View article]
    "that sure was a huge vote of confidence them partnering with ADMP"

    No profit sharing, royalties, upfront payment or milestones constitutes a partnership to you? They just buy tape off of 3M. Partnership!!! lol.

    I'm off but i'll be back to remind everyone of the DILUTION that will be coming down the line. IMO.
    May 23, 2014. 04:52 PM | 1 Like Like |Link to Comment
  • 4 Reasons Adamis Pharmaceuticals Could Be A Multi-Bagger [View article]
    " So when you can't answer a question you just start spamming a new string?"

    Why don't you ask 3M why they sold the device for PITTANCE and why they didn't even bother to test it in a POC clinical trial like they do with all there other devices. In fact you will see one of the in vivo results PR's back in 2011 that they have planned further testing in human trials but they obviously didn't want to bother and sold it instead for PITTANCE. Your talking about a product that MAY get approved in 3 years by a company who has no experience of bringing a product through clinical trials and dealing with the FDA (oh wait they already felt the wrath of the FDA). Also 3M also had the option to invest in this company on the cheap and they walked away.

    "Take it to the Yahoo boards."

    Are you kidding me? You don't even bother to tell the FULL story. Funding is the life blood of a small development stage biotech like this one. The talk of a partnership is all spiel. They need 10's of millions going forward and the capital markets is where they will have to get it. IMO. This notion that they'll just do a POC trial and viola a partner with upfront money will come is ridiculous. Of course the management "believe" it so it must be going to happen. Geez if i had a penny ..... :)
    May 23, 2014. 04:28 PM | 1 Like Like |Link to Comment
  • 4 Reasons Adamis Pharmaceuticals Could Be A Multi-Bagger [View article]
    Management will DILUTE this stock into oblivion. They NEED $10m for the new molds BEFORE they can begin the pivotal trial for the Taper DPI device. This does not include any trial expenses. Chances of upfront payment from a partner are tiny. IMO.

    Keep drinking the koolaid.
    May 23, 2014. 02:34 PM | Likes Like |Link to Comment
  • 4 Reasons Adamis Pharmaceuticals Could Be A Multi-Bagger [View article]
    "1) At no time did management suggest that manufacturing costs would be zero. Are you suggesting that the device should have no manufacturing costs? Or that the molds would be thrown in the trash after the trial"

    A simple YES would have sufficed. Thank you for clarifying that the company will NEED $10m BEFORE they can begin the pivotal trial.

    "2) Y.E.S."

    Good luck with that. :)

    "Is that you in the mugshot?"

    Ad hominem attacks are a sign of weakness. Thanks for the laugh though.
    May 23, 2014. 02:30 PM | Likes Like |Link to Comment
  • 4 Reasons Adamis Pharmaceuticals Could Be A Multi-Bagger [View article]
    " They need, and have, half a million to do the POC, not $10 million, where do you get sidestep?"

    Mea culpa. They NEED $10m to create new molds for the Taper DPI device BEFORE they can begin the pivotal clinical trial. Yes that's right i forgot to put "pivotal" in front of the words "clinical trial". Please move on cause i know you're going to use this faux pas as a way to side-step this important issue again.

    Please clarify for your readers that management talked about this $10m for creating the new molds that you never mentioned in your article? Also are you somehow saying that a partner will fund this through an upfront payment based on a tiny POC trial?

    2 simple questions that require 2 simple answers.
    May 23, 2014. 02:09 PM | 1 Like Like |Link to Comment
COMMENTS STATS
70 Comments
53 Likes